| Date | Time | Source | Headline | Symbol | Company |
| 11/01/2011 | 5:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/01/2011 | 4:55PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/01/2011 | 8:58AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 11/01/2011 | 7:00AM | Business Wire | Impax Laboratories Reports Third Quarter 2011 Financial Results | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 10/28/2011 | 6:45PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 10/20/2011 | 8:57AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 10/18/2011 | 10:37AM | PR Newswire (US) | Perrigo Confirms Filing for Generic Version of PATANASE® Nasal Spray and Announcement of Patent Infringement Lawsuit by Alco... | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 10/13/2011 | 5:46PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 10/11/2011 | 9:00AM | Business Wire | Impax Laboratories Schedules Conference Call and Webcast for Third Quarter 2011 Financial Results | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 10/07/2011 | 10:30AM | Zacks | Generic Threat for Warner Chilcott - Analyst Blog | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 10/07/2011 | 9:00AM | Marketwired | Expert's Economic Outlook, Global - Equity Research on Impax Laboratories Inc and Enzo Biochem, Inc. | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/30/2011 | 9:30AM | Zacks | Relief for Warner Chilcott - Analyst Blog | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/22/2011 | 9:30AM | Business Wire | Impax Laboratories to Present at the Jefferies Global Healthcare Conference in London | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/14/2011 | 9:15AM | Business Wire | Impax Laboratories to Present at the UBS Global Life Sciences Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/13/2011 | 11:59AM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/12/2011 | 5:30PM | Business Wire | Impax Laboratories Confirms Patent Challenge Relating to Generic JALYN® 0.5 mg/0.4 mg | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/06/2011 | 5:34PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 09/06/2011 | 8:39AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/31/2011 | 8:30AM | Business Wire | Impax Laboratories Confirms Patent Challenge Relating to Generic NUEDEXTA® 20 mg/10 mg | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/17/2011 | 9:00AM | Marketwired | Analyst View, Current Global Forecast - Equity Research on Impax Laboratories Inc. and Mylan Inc. | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/16/2011 | 3:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/16/2011 | 8:08AM | Zacks | Positive Data on Glaxo Drug - Analyst Blog | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/15/2011 | 7:49AM | Dow Jones News | GSK, Impax: Positive Top-Line Results Of ASCEND-PD Phase III Study | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/15/2011 | 7:00AM | Business Wire | Impax and GSK Announce Positive Topline Results of ASCEND-PD Phase III Study of IPX066 in Advanced Parkinson’s Disease | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/08/2011 | 4:50PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/05/2011 | 5:54PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/04/2011 | 4:28PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/03/2011 | 11:29AM | Zacks | Higher Revenues at Shire - Analyst Blog | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/02/2011 | 11:00AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 08/02/2011 | 7:00AM | Business Wire | Impax Laboratories Reports Second Quarter 2011 Financial Results | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |